rhamnosus GG showing the strongest GPX1 recovery
Quality, transparency, and reliable documentation are the foundational requirements for research-grade compounds, and PSPeptides meets all three
A recent Phase 2 randomised placebo-controlled trial tested efinopegdutide in people with obesity over a 26-week period, where participants were randomly assigned weekly treatment with either placebo, 5 mg, 7.4 mg, 10 mg efinopegdutide, or 3 mg liraglutide daily
Additionally, research peptides are endotoxin tested to ensure consistency and reliability across in vitro and non-clinical investigative studies
10.1038/aps.2014.41 60 LinM.ZhaiX.WangG.TianX.GaoD.ShiL.et al (2015)
Mold toxicity is diagnosed through structured clinical evaluation rather than a single test